MDL-100240

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameMDL-100240

Drug Alias Name100240MDL-100240M-100240

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAngiotensin-converting enzyme inhibitorsNeprilysin inhibitors

TargetsAngiotensin-converting enzymeNeprilysin

Therapy Area/IndicationsHypertensionHeart Failure

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsHypertensionHeart Failure

ATC CodeN/A